Clinical Trials on Glycogen Storage Disease Type IIb in Japan
Total 1495 results
-
Osaka City UniversityCompleted
-
Tokyo Women's Medical UniversityCompletedKidney Cancer | Metastatic CancerJapan
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
National Cancer Center Hospital EastBayer Yakuhin, Ltd.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myelogenous LeukemiaJapan
-
Eli Lilly and CompanyCompletedColorectal CarcinomaJapan
-
Kumamoto UniversityCompletedCoronary Disease | Arteriosclerosis | Diabetes Mellitus, Type 2Japan
-
Astellas Pharma IncCompleted
-
Eisai Inc.Completed
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedUterine Leiomyomata (Fibroids)Japan
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Chile, France, Germany, Italy, Japan, Netherlands, Portugal, Spain, Tunisia, Turkey, United Kingdom
-
TakedaRecruiting
-
Aichi Gakuin UniversityUnknown
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
GlaxoSmithKlineActive, not recruiting
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's LymphomaJapan
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IIA Cervical Cancer AJCC v7 | Stage IB Cervical Cancer AJCC v6 and v7 | Stage I Cervical Cancer AJCC v6 and v7 | Stage IA Cervical Cancer AJCC v6 and v7United States, Korea, Republic of, Japan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Eli Lilly and CompanyCompleted
-
Kyowa Kirin Co., Ltd.CompletedAdult T-Cell Leukemia and Lymphoma (ATL) | Adult Peripheral T-Cell Lymphoma (PTCL)Japan
-
Chugai PharmaceuticalCompleted
-
Wakayama Medical UniversityOsaka University; Kyoto Prefectural University of Medicine; Nara Medical University and other collaboratorsCompletedPancreatic Cancer | Chronic Pancreatitis | Pancreatic Cystic Lesions | Pancreatic Neuroendocrine Tumors | Pancreatic PseudocystsJapan
-
Zeria PharmaceuticalCompletedMetastatic Pancreatic AdenocarcinomaJapan, Korea, Republic of, Taiwan
-
Sumitomo Pharma Co., Ltd.CompletedNon-Small Cell Lung Cancer | Malignant Pleural MesotheliomaJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 1 Diabetes MellitusJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
Bristol-Myers SquibbCompleted
-
Advanced-JJapan Heart FoundationUnknownHypertension | Diabetes Mellitus, Type 2Japan
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaJapan
-
Bristol-Myers SquibbRecruitingPeripheral T-cell LymphomaJapan
-
Kosei Hasegawa, MD, PhDRecruitingCarcinoma, Ovarian EpithelialJapan
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Kindai UniversityUnknownCarcinoma, Hepatocellular | Hepatocellular Carcinoma | Liver Neoplasm | Unresectable Hepatocellular CarcinomaJapan
-
CelgeneRecruiting
-
Cancer Intelligence Care Systems, Inc.Stella Pharma CorporationCompletedAngiosarcoma | Malignant MelanomaJapan
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Japan Clinical Cancer Research OrganizationTaiho Pharmaceutical Co., Ltd.Unknown
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Merck Sharp & Dohme LLCCompletedCondyloma Acuminata | Anogenital Human Papilloma Virus InfectionJapan
-
Aichi Gakuin UniversityUnknown
-
Janssen Pharmaceutical K.K.Pharmacyclics LLC.CompletedRecurrent Mature B-cell NeoplasmsJapan
-
Telix International Pty LtdCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaJapan
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan